Arkolith/Insider Trading/LFCR/Form 4

Josephs Paul

Chief Executive Officer, DirectorLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) · full profile →Form 4 · filed Jul 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 8, 2025Option exercise(M)150K——688K
Jul 8, 2025Tax withholding(F)55K$8.19$449K633K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 8, 2025Option exercise(M)150K——1.4M

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001005286-25-000078) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML